These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer. Iantorno R; Nicolai M; Storto ML; Ciccotosto C; Cipollone G; Mastroprimiano G; Tenaglia RL J Urol; 1998 May; 159(5):1639-40. PubMed ID: 9554372 [No Abstract] [Full Text] [Related]
86. Intravesical bacillus Calmette-Guerin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy. Pisters LL; Tykochinsky G; Wajsman Z J Urol; 1991 Dec; 146(6):1514-7. PubMed ID: 1942330 [TBL] [Abstract][Full Text] [Related]
88. A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: is it effective? Pagano F; Bassi P; Milani C; Meneghini A; Maruzzi D; Garbeglio A J Urol; 1991 Jul; 146(1):32-5. PubMed ID: 2056600 [TBL] [Abstract][Full Text] [Related]
89. Insignificant role of bacillus Calmette-Guérin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial. Nakai Y; Anai S; Tanaka N; Chihara Y; Haramoto M; Otani T; Nakagawa Y; Hirao Y; Konishi N; Fujimoto K Int J Urol; 2016 Oct; 23(10):854-860. PubMed ID: 27416975 [TBL] [Abstract][Full Text] [Related]
90. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. Yutkin V; Pode D; Pikarsky E; Mandelboim O J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285 [TBL] [Abstract][Full Text] [Related]
91. The possible influence of antibiotics on results of bacillus Calmette-Guérin intravesical therapy for superficial bladder cancer. van der Meijden PM; van Klingeren B; Steerenberg PA; de Boer LC; de Jong WH; Debruyne FM J Urol; 1991 Aug; 146(2):444-6. PubMed ID: 1856950 [TBL] [Abstract][Full Text] [Related]
92. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. Brake M; Loertzer H; Horsch R; Keller H J Urol; 2000 Jun; 163(6):1697-701. PubMed ID: 10799163 [TBL] [Abstract][Full Text] [Related]
93. Fibronectin expression on surgical specimens correlated with the response to intravesical bacillus Calmette-Guerin therapy. Fleischmann JD; Park MC; Hassan MO J Urol; 1993 Feb; 149(2):268-71. PubMed ID: 8426398 [TBL] [Abstract][Full Text] [Related]
94. Intravesical bacillus Calmette-Guérin and second primary malignancies. Guinan P; Brosman S; DeKernion J; Lamm D; Williams R; Richardson C; Reitsma D; Hanna M Urology; 1989 May; 33(5):380-1. PubMed ID: 2711556 [TBL] [Abstract][Full Text] [Related]